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Expression of urokinase-type plasminogen activator receptor 
mRNA was examined in villa in mouse skin wounds by in situ 
hybridization. Urokinase-type plasminogen activator recep-
tor mRNA was found in keratinocytes at the front of the 
regenerative epithelial outgrowths at the edge of 12-, 48-, 
and 96-hour-old wounds. The signal was strongest in the 
keratinocytes just beginning to move 12 h after wounding. 
At later timepoints the signal was weaker, but still confined 
to keratinocytes at the wound edges. Using in situ hybridiza-
tion, no cells expressing urokinase-type plasminogen activa-
tor receptor mRNA could be detected in normal epidermis, 
in normal-looking epidermis adjacent to the wounds, in 
dermis, in subcutis, or in newly formed granulation tissue. 
D uring re-epithelialization of injured skin the kerati-nocytes at the wound edge migrate under the wound clot until contact is established with the op-posing front of keratinocytes and the epidermal de-fect is closed. Mitotic activity is seen only in trailing 
basal cells [1]. The provisional extracellular matrix in the wound 
clot consists mainly of fibrin and fibronectin and is traversed by the 
migrating keratinocytes. These cells must therefore be capable of 
degrading this extracellular matrix, and ill vitro the urokinase-type 
plasminogen activator (uPA), an enzyme which activates plasmino-
gen to plasmin, has been found in migrating keratinocytes [2] and in 
endothelial cells at the edge of experimental wounds [3]. We have 
previously found that both uP A and type-1 plasminogen activator 
inhibitor (PAl-I) ill vivo are expressed in migrating keratinocytes 
during healing of human and murine skin wounds, uPA protein and 
mRNA being present in several layers of keratinocytes in the epi-
thelial outgrowth, whereas PAI-l mRNA is confined to the basal 
keratinocytes and the P AI-1 protein to these cells and the basement 
membrane below [4,5]. 
uP A activity can be localized pericellularly by the binding of uP A 
to a specific cell surface receptor (uPAR) [6-8). uPAR is a highly 
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The specificity of the results was supported by the use of 
antisense RNA from two different non-overlapping cDNA 
clones and the corresponding sense RNA probes, and by 
Northern analysis of tissue extracts. Together with previous 
findings on expression of urokinase-type plasminogen acti-
vator and its type 1 inhibitor, the localized and regulated 
expression of urokinase-type plasminogen activator receptor 
mRNA during skin wound healing indicates that focal extra-
cellular proteolysis at the cell surface generated by receptor-
bound urokinase-type plasminogen activator is implicated in 
the migration of re-epithelializing keratinocytes. Key words: 
urokinase-type plasminogen activator receptor mRNA/keratino-
cytes/mouse skin wounds.] Invest Dermatol1 02:519-522, 1994 
glycosylated 55 - 60-kilodalton (kD) single polypeptide-chain pro-
tein consisting of three internal repeats of which the N-terminal in 
human uPAR has been shown to constitute the uPA binding do-
main [9). C-terminally human and mouse uPAR are attached to the 
cell membrane by a phosphatidylinositol glycolipid anchor [8,10]. 
Both active uPA and its proenzyme pro-uPA bind to uPAR with 
high affinity. Receptor-bound pro-uPA can be activated to uPA by 
plasmin, and receptor-bound uPA can activate plasminogen [11]. 
Binding of both pro-uPA and plasminogen to cell surfaces strongly 
acc.el~rates plasmin gen~ration [12], and localized pericellular uPA 
aCtlVlty appears to reqUlre the concomitant expression of uP A and 
uPAR (reviewed in [13]). 
A high-affinity binding site for uPA has been demonstrated on 
the surface of cultured human keratinocytes [14,15), and in 
wounded keratinocyte cultures receptor-bound uPA was detected 
on the cells at the leading edge of the migrating epithelial sheet (14). 
We have now investigated the expression of uPAR mRNA during 
mouse skin wound healing by ill situ hybridization. 
MATERIALS AND METHODS 
Materials Materials used were T7 , T3, and SP6 polymerase, pBluescript 
KS(+) plasmid vector, and poly(A)quik Oligo dT-columns (Strata gene, 
CAl, pGEM5z plasmid vector, RNasin, and DNase I (Promega, WI), KS 
autoradiographic emulsion (Ilford, Cheshire, U.K.), deoxycytidine 5'-[0'-
32P] triphosphate (3000 Cijmmol) (Amersham, U.K.) , 35S-UTP (Du-
pont-NEN, MA), and random priming DNA labeling kit, dithiothreitol, 
and restriction endonucleases (Boehringer, Mannheim, Germany). 
Cell Culture The mouse macrophage cell line P388D.1 [American Type 
Culture Collection (ATCC, Rockville, MD)] was grown in Dulbecco's 
modified Eagle's medium (DMEM) (Flow Laboratories, Scotland) with 10% 
fetal bovine serum and harvested as in [8]. 
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Aninlals and Tissue Treatment Procedures Experimental wounding 
was performed on 10-12-week-old female Balb/c mice (5) . Ten control 
animals, ten animals with 12-hour-old wounds, and ten arumals with 48-
hour- old wounds were perfused intracardially with 20 m14 · C phosphate-
buffered saline (PBS) and the wounds, surrounded by a 1-mm rim of skin 
(total weight approximately 100 mg), were removed surgically and used for 
RNA extraction. 
Four control animals, four animals with 12-hour-old wounds, four ani-
mals with 48-hour-old wounds, and six animals with 96-hour-old wounds 
were treated similarly, except that perfusion with cold PBS was followed by 
intracardial perfusion-fixation with 4% paraformaldehyde in 0.1 M PBS 
(PFA). The wound area was cut in 3-mm slices perpendicular to the wound. 
These specimens were postfixed for 16 h in 4% PFA, rinsed for 6 h in 0.1 M 
sodium phosphate, pH 7.4, 20% (w/v) sucrose, frozen in melting Freon 22, 
and stored at -80·C until further use. 
Preparation of RNA Probes and In Situ Hybridization The follow-
ing fragments of mouse uPA cDNA [16) and mouse uPAR cDNA [7) were 
subcloned: pMUPA07, (608)-(1642) fragment in pGEM5z; pMUPA09, 
(37)-(428) fragment; p50A/l, (0)-(362); p50A/8, (700)-(1186), all in 
pBluescript KS(+). The last rwo plasmids are fragments of mouse uPAR 
cDNA covering sequences that are identical in the mouse uPARl and 
uPAR2 cDNAs [7). 35S-UTP-labeled antisense or sense RNA probes (1 X 
106 cpml,ul) were generated by transcription of these plasmids using the 
relevant polymerase (SP6, T3, T7), and were then used for itl situ hybridiza-
tion on cryostat sections of normal and wounded mouse skin tissue [5,17). 
RNA Isolation and Northern Analysis Total RNA extracts were made 
from frozen tissue, poly(A)+ RNA was isolated by chromatography of 
400 ,ug from a pool of total RNA using columns of oligo (dT) cellulose, and 
agarose-separated poly(A+) RNA were blotted onto reinforced nitrocellu-
lose membranes. The membranes were hybridized with the 32P "random 
prime"-labeled cDNA probes pMUPA07 and p50A/l, which were also 
used for generation of RNA probes. pGAPDH 5, containing a full-length 
cDNA for the rat glyceraldehyde 3-phosphate dehydrogenase inserted into 
the Pst! site of pUC 19, was used as control probe [5). 
RESULTS 
uPAR mRNA in Wound Extracts Total RNA was extracted 
from normal mouse skin and skin wound tissue. Poly(A)+ RNA was 
isolated and analyzed by Northern blotting with uPAR eDNA. As 
shown in Fig I, weak expression of the 1.5-kilobase (kb) band is 
seen in the normal skin. Twelve hours after wounding, a strong 
increase of the 1.5-kb band and induction of an upper 1.7-kb band 
are seen. Forty-eight hours after wounding both these bands are 
noticeably weaker. The 1. 7 - and 1.5-kb bands in the wound extracts 
co-migrate with the two uPAR mRNA bands found in poly(A)+ 
RNA from cultured mouse macrophage P388D.l cells (Fig l,lane 
4). We have previously shown that the two bands in these latter 
cells represent uP AR mRN As differing in the length of the 3' end 
non-coding part [8]. Rehybridization of the membrane with a rat 
GAPDH eDNA probe shows that the lanes with normal skin and 
wound extracts contained virtually equal amounts of this mRNA 
(Fig I, lower palle0· 
In Situ Hybridization To determine the localization of the 
uPAR mRNA in the mouse skin wounds, in situ hybridization was 
performed. Sections of normal skin, and of 12-,48-, and 96-hour-
old wounds were examined using two different non-overlapping 
antisense mouse uPAR RNA probes. Twelve hours after wounding, 
a strong signal for mouse uPAR mRNA is seen in the keratinocytes 
at the edge of the wound (Fig 2a,b). At this point the keratinocytes 
have barely begun to move, but the epidermal layer has thickened 
and keratinocytes in all layers at the edge of the wound show a 
signal. At the same timepoint the keratinocytes on an adjacent sec-
tion show a strong signal for uPA mRNA after hybridization with 
an antisense uPA RNA probe (Fig 2d,e), in accordance with previous 
observations [5]. Sections of 48- and 96-h-old wounds also show a 
uPAR mRNA signal in keratinocytes, but it is weaker than that seen 
12 h after wounding. Forty-eight and 96 h after wounding, uP AR 
mRNA is expressed only in the keratinocytes at the very front of the 
regenerative epithelial outgrowths at the edge of the wounds (see 
Fig 2g,/t). In contrast, a strong signal is seen in both basal and supra-
basal keratinocytes of the entire epithelial outgrowth when adjacent 
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Figure 1. Northern blot analysis of uPAR mRNA in extracts of skin from 
normal mice (lane 1) or skin wounds at 12 h (lane 2) and 48 h (lane 3) after 
wounding. In each lane, 2.5,ug of poly(A)+ RNA were electrophoresed in 
1.5% agarose gels under denaturing conditions and blotted onto a nitrocel-
lulose membrane. The membrane was hybridized with a random primed 
mouse uPAR eDNA. After probe stripping, the membrane was rehybridized 
with GAPDH cDNA (lower patlel), to test whether the same amount of 
poly(A)+ RNA was transferred to the membrane in each latle. The 1.7- and 
1.5-kb bands in the wound extracts co-migrate with the bands found in 
poly(A)+ RNA from cultured mouse macrophage P388D.l cells (lane 4) by 
hybridization with a mouse uPAR antisense RNA probe. The positions of 
ribosomal RNAs are indicated to the left, and the apparent size of the uPAR 
mRNA bands to the right. 
sections of the same wounds are hybridized with an antisense uPA 
RNA probe, in agreement with previous findings [5] and demon-
strating that the mRNA in these cells was intact (results not shown). 
No hybridization signals for uPAR mRNA were observed in 
epidermis, dermis, and subcutis in normal-looking skin adjacent to 
the wounds and skin from normal mice (Fig 2j,k). Neither was any 
signal observed in the granulation tissue of the wounds . 
The specificity of all the in situ hybridizations was controlled on 
adjacent sections, with the corresponding sense probes for mouse 
uPAR and uPA mRNA all with the same radioactivity (cpm/ILl) as 
the respective antisense transcripts (Fig 2e,j,i, and 0. This back-
ground was always much less pronounced than the signals described 
above with the antisense RNA probes. In addition, the specificity of 
the signals was confirmed by using two non-overlapping RNA an-
tisense probes for both uPAR and uPA mRNA. In all cases, identical 
hybridization results were obtained with the two different probes. 
DISCUSSION 
The expression of uPAR mRNA in the keratinocytes at the border 
of the 12-h-old wound clot, and our previous finding of both uPA 
and PAI-l mRNA at the same timepoint in similarly located kerati-
nocytes [5], point to a role for the uPA pathway of plasminogen 
activation in early events of the re-epithelialization process. The 
expression of uPAR mRNA declines at later timepoints, but is still 
detected 48 and 96 h after wounding confined to the front of the 
moving keratinocytes. This expression is different from the expres-
sion of uPA mRNA, which is found both in the basal and suprabasal 
keratinocytes of the whole epithelial outgrowth (sec Fig 2 and [5]). 
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Figure 2. Localization of uPAR mRNA in keratinocytes at the leading edge of healing mouse skin wounds by ill situ hybridization. A strong signal for uPAR 
mRNA is present in the moving keratinocytes at the edge of 12-hour- old wounds (a,b), whereas lIPA mRNA can be detected in all keratinocytes close to the 
wound area in an adjacent section (d, e). Ninety-six hours after wounding, uPAR mRNA is still detected only in the front of the epitheliaI outgrowth (g,h) . No 
signal for uPAR mRNA could be detected in normal mouse skin (j,k). No specific hybridiza tion was seen with sense uPAR (c, i, and /) or sense uPA (f) RNA 
probes. Arrows, leading front of keratinocytes. Bars, 60 Jim. 
The finding of highly regulated expression of uPAR mRNA is in 
agreement with the Northern analysis of wound extracts, showing a 
strong uPAR mRNA expression 12 h after wounding and a consid-
erably lower expression 48 h after wounding. In normal skin low 
amounts of uPAR mRNA were found in extracts, but could not be 
de tected by in sitll hybridization, probably reflecting that there is a 
low expression in many cells, e.g., in blood leukocytes, which have 
been found previously to express uPAR mRNA [18] . 
In addition to the 1.5-kb uPAR mRNA fo und in normal skin, a 
1.7-kb uPAR mRNA was also induced in the wound extracts. This 
probably rerresents a variant mRNA with a longer 3'end non-cod-
ing region [8] . Another possibility is that the 1.7-kb mRNA is a 
previously described alternatively spliced mouse uPAR2 mRNA 
variant (7). This, however, is not likely because uPAR2 could not be 
detected in the wounds at any timepoint by ill situ hybridization 
with a uPAR2-specific probe. In addition, only uPAR 1 was detected 
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in wound RNA extracts by polymerase chain reaction (PCR) ampli-
fication; RNA was isolated from the wounds and from uPAR1- or 
uPAR2-transfected COS cells as positive controls and cDNA was 
synthesized with reverse transcriptase. This cDNA was analyzed for 
the presence of uPAR1 and 2 by PCR amplification with primers 
flanking the insert region in uPAR2 mRNA. Southern analysis of 
the amplified fragments showed that only uP AR 1 mRNA is present 
in the wound extracts (unpublished results). 
The moving keratinocytes may use surface-bound plasmin, 
formed by receptor-bound uPA, for degradation of extracellular 
matrix proteins when they dissect their way under the wound clot. 
In addition, receptor-bound uPA can be more directly involved in 
the process of cell migration. In some cell types occupied uP AR is 
preferentially located at cell-cell and focal cell-substratum contact 
sites [19,20], and a similar location of receptor-bound uPA was 
recently reported in cultured keratinocytes [21]. A regulated activa-
tion of the uP A system may be involved in the breakdown of these 
contact sites during keratinocyte migration. 
Recent in situ hybridization studies of human squamous cell car-
cinomas of the skin have shown that both uPA [22,23] and uPAR 
(Charles Pyke, unpublished results) are expressed by the cancer cells 
especially at the invasive foci, suggesting that the simultaneous 
expression of uP A and its receptor by the epidermally derived cancer 
cells plays a role during invasive growth of the carcinomas. The 
expression of uP A and its receptor by epithelial cells during both 
skin wound healing and squamous cell carcinoma invasion suggests 
that there are similarities between the mechanisms of generation 
and regulation of extracellular proteolysis in the two processes. A 
crucial difference, however, is that the expression of uPA and uPAR 
in the migrating keratinocytes is downregulated when the skin 
wound is covered with epidermis, whereas a similar downregula-
tion appears to be lacking in the squamous carcinoma cells. This 
difference in regulation may be an important reason for tumors 
behaving as "wounds that do not heal" [24] . uP A and uP AR expres-
si,?n in cultured cells is regulated by a variety of cytokines [13], and 
the role of cytokines in the regulation of these molecules should be 
studied in wound healing and skin cancer invasion ill vivo to get an 
insight into the molecular mechanism behind the differences be-
tween the two processes. 
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